Published in J Lab Clin Med on December 01, 1998
Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci (2007) 0.90
Characterization of gastric myoelectrical rhythms in patients with systemic sclerosis using multichannel surface electrogastrography. Dig Dis Sci (2002) 0.88
Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma. BMC Gastroenterol (2008) 0.77
Anorectal motility and sensation abnormalities and its correlation with anorectal symptoms in patients with systemic sclerosis: a preliminary study. ISRN Gastroenterol (2011) 0.76
Healing of duodenal ulcer with an antacid regimen. N Engl J Med (1977) 3.32
Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol (2000) 3.08
Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology (1990) 3.04
The physiology and pathophysiology of gastric emptying in humans. Gastroenterology (1984) 2.93
Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci (1998) 2.84
Acute flank pain: comparison of non-contrast-enhanced CT and intravenous urography. Radiology (1995) 2.81
Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil (2006) 2.61
Cyclic vomiting syndrome in adults. Neurogastroenterol Motil (2008) 2.40
Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology (1985) 2.37
Clinical approaches to irritable bowel syndrome. Lancet (1992) 2.28
Gastric emptying in patients with gastroesophageal reflux. Gastroenterology (1981) 2.02
Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr (1997) 1.79
Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis. Gastroenterology (1988) 1.77
Impact of acid and pepsin on human esophageal prostaglandins. Am J Gastroenterol (1994) 1.75
Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol (1993) 1.70
Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther (2007) 1.65
Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia. Gastroenterology (1987) 1.64
Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis. Dig Dis Sci (1996) 1.62
Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data. Aliment Pharmacol Ther (2011) 1.62
Enhancement of salivary esophagoprotection: rationale for a physiological approach to gastroesophageal reflux disease. Gastroenterology (1996) 1.57
The hypertensive lower esophageal sphincter. Manometric and clinical aspects. Dig Dis Sci (1989) 1.54
Fast spin-echo MR imaging of the female pelvis. Part I. Use of a whole-volume coil. Radiology (1992) 1.51
Viral gastroparesis: a subgroup of idiopathic gastroparesis--clinical characteristics and long-term outcomes. Am J Gastroenterol (1997) 1.51
The role of prolonged esophageal pH monitoring in the diagnosis of gastroesophageal reflux. JAMA (1984) 1.49
Metoclopramide: pharmacology and clinical application. Ann Intern Med (1983) 1.49
Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score. Am J Gastroenterol (1993) 1.48
Characteristics of transient lower esophageal sphincter relaxation in humans. Am J Physiol (1987) 1.46
Monophasic luminal release of prostaglandin E2 in patients with reflux esophagitis under the impact of acid and acid/pepsin solutions. Its potential pathogenetic significance. J Clin Gastroenterol (1995) 1.45
Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). Cancer Res (1973) 1.45
Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. Aliment Pharmacol Ther (1999) 1.44
Spontaneous peritonitis in cirrhotic ascites. A decade of experience. Am J Dig Dis (1974) 1.43
Effects of pacing parameters on entrainment of gastric slow waves in patients with gastroparesis. Am J Physiol (1998) 1.43
A 20-minute breath test for helicobacter pylori. Am J Gastroenterol (1991) 1.43
Superiority of the flexible to the rigid sigmoidoscope in routine proctosigmoidoscopy. N Engl J Med (1980) 1.40
The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol (1993) 1.38
Serosal and cutaneous recordings of gastric myoelectrical activity in patients with gastroparesis. Am J Physiol (1994) 1.36
Intraventricular hemorrhage in the preterm neonate: timing and cerebral blood flow changes. J Pediatr (1984) 1.35
Pneumothorax and dependent versus nondependent patient position after needle biopsy of the lung. Radiology (1999) 1.34
Modulation of feline esophageal contractions by bolus volume and outflow obstruction. Am J Physiol (1990) 1.34
Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg (2001) 1.33
Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil (2009) 1.32
Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. Am J Gastroenterol (1993) 1.29
Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil (2010) 1.29
Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia. Am J Gastroenterol (1999) 1.27
Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial. Adv Med Sci (2007) 1.26
Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium. Neurogastroenterol Motil (2012) 1.25
The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology. Aliment Pharmacol Ther (2009) 1.25
Electrical and mechanical activity in the human lower esophageal sphincter during diaphragmatic contraction. J Clin Invest (1988) 1.22
Association of the status of interstitial cells of Cajal and electrogastrogram parameters, gastric emptying and symptoms in patients with gastroparesis. Neurogastroenterol Motil (2009) 1.21
Interaction of levodopa and metoclopramide on gastric emptying. Clin Pharmacol Ther (1980) 1.20
Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepat (2004) 1.19
Scintigraphic determination of small intestinal transit time: comparison with the hydrogen breath technique. Gastroenterology (1984) 1.19
Metoclopramide stimulates prolactin secretion in man. J Clin Endocrinol Metab (1976) 1.18
Clinical applications of electrogastrography. Am J Gastroenterol (1993) 1.17
Radionuclide esophageal emptying of a solid meal to quantitate results of therapy in achalasia. Gastroenterology (1983) 1.17
Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology (2000) 1.15
Cisapride: a new class of prokinetic agent. The ACG Committee on FDA-related matters. American College of Gastroenterology. Am J Gastroenterol (1991) 1.14
Gastric slow wave abnormalities in patients with gastroparesis. Am J Gastroenterol (1992) 1.13
Review article: cyclic vomiting syndrome in adults--rediscovering and redefining an old entity. Aliment Pharmacol Ther (2011) 1.13
Human lower esophageal sphincter pressure response to increased intra-abdominal pressure. Am J Physiol (1990) 1.13
Artifact reduction in electrogastrogram based on empirical mode decomposition method. Med Biol Eng Comput (2000) 1.12
Acceleration of gastric emptying with electrical stimulation in a canine model of gastroparesis. Am J Physiol (1992) 1.12
Motility of the antroduodenum in healthy and gastroparetics characterized by wireless motility capsule. Neurogastroenterol Motil (2010) 1.12
Median arcuate ligament syndrome: a possible cause of idiopathic gastroparesis. Am J Gastroenterol (1997) 1.10
Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. Gastroenterology (1983) 1.10
Electrogastrography: measurement, analysis and prospective applications. Med Biol Eng Comput (1991) 1.09
The clinical value of ascitic fluid culture and leukocyte count studies in alcoholic cirrhosis. Gastroenterology (1976) 1.08
Human esophageal secretion: mucosal response to luminal acid and pepsin. Gastroenterology (1994) 1.07
Fibroma and fibrothecoma of the ovary: MR imaging findings. Radiology (1997) 1.07
Do bile acids reflux into the esophagus? A study in normal subjects and patients with gastroesophageal reflux disease. Gastroenterology (1987) 1.07
The antitumor agent cis-Pt(NH 3 ) 2 Cl 2 : distribution studies and dose calculations for 193m Pt and 195m Pt. J Nucl Med (1973) 1.07
Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration. Gastroenterology (1984) 1.05
Clinical significance of gastric myoelectrical dysrhythmias. Dig Dis (1996) 1.05
Ultrastructure of another spiral organism associated with human gastritis. Dig Dis Sci (1989) 1.05
Efficiency and efficacy of multi-channel gastric electrical stimulation. Neurogastroenterol Motil (2005) 1.05
Tonic dopaminergic suppression of plasma aldosterone. J Clin Endocrinol Metab (1980) 1.05
Definition of a gastric emptying abnormality in patients with anorexia nervosa. Dig Dis Sci (1985) 1.04
Esophageal disease in patients with angina-like chest pain. Am J Gastroenterol (1981) 1.04
A new percutaneous approach for the treatment of hydatid cysts of the liver. Am J Gastroenterol (2001) 1.03
Gastroduodenal mucus gel thickness in patients with Helicobacter pylori: a method for assessment of biopsy specimens. Am J Gastroenterol (1991) 1.03
The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol (1997) 1.02
Effect of the diaphragmatic contraction on lower oesophageal sphincter pressure in man. Gut (1987) 1.02
Medication-induced esophageal injury: survey of the literature. Am J Gastroenterol (1987) 1.02
Postprandial response of gastric slow waves: correlation of serosal recordings with the electrogastrogram. Dig Dis Sci (2000) 1.02
Sleep and nocturnal acid reflux in normal subjects and patients with reflux oesophagitis. Gut (1991) 1.02
Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. AJR Am J Roentgenol (1999) 1.01
Sphincteric action of the diaphragm during a relaxed lower esophageal sphincter in humans. Am J Physiol (1989) 1.01
The role of nifedipine therapy in achalasia: results of a randomized, double-blind, placebo-controlled study. Am J Gastroenterol (1989) 1.00
Experience with herpes esophagitis in otherwise healthy patients. Am J Gastroenterol (1984) 1.00
Spectrum of gastric emptying patterns in adult patients with cyclic vomiting syndrome. Neurogastroenterol Motil (2010) 1.00
Identification of gastric contractions from the cutaneous electrogastrogram. Am J Gastroenterol (1994) 0.99
Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol Motil (2006) 0.99
Association of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis. Neurogastroenterol Motil (2014) 0.99
Effect of high-frequency gastric electrical stimulation on gastric myoelectric activity in gastroparetic patients. Neurogastroenterol Motil (2004) 0.99